|
HS Code |
690118 |
| Chemical Formula | C4H3N3S |
| Molar Mass | 125.15 g/mol |
| Appearance | Solid |
| Melting Point | 199 - 202 °C |
| Solubility In Water | Poorly soluble |
| Solubility In Organic Solvents | Soluble in some organic solvents like DMSO |
| Stability | Stable under normal conditions, but may react with strong oxidizing or reducing agents |
As an accredited 2-Aminothiazole-4-Carbonitrile factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 500g of 2 - Aminothiazole - 4 - Carbonitrile packaged in a sealed, labeled plastic bag. |
| Shipping | 2 - Aminothiazole - 4 - Carbonitrile is shipped in sealed, corrosion - resistant containers. It follows strict chemical shipping regulations, ensuring proper handling to prevent spills and maintain product integrity during transit. |
| Storage | 2 - Aminothiazole - 4 - Carbonitrile should be stored in a cool, dry place away from heat and ignition sources. Keep it in a tightly closed container to prevent exposure to air and moisture, which could potentially lead to decomposition or degradation. Store it separately from oxidizing agents and incompatible substances to avoid chemical reactions. |
|
During the route scouting for a second-generation aminothiazole-based kinase inhibitor destined for a GMP campaign exceeding 150 kg of API output, the crystalline intermediate 2-aminothiazole-4-carbonitrile was introduced at the penultimate stage to circumvent the genotoxic impurity liabilities observed with earlier nitrile-free analogues. The compound’s electron-deficient thiazole ring and free amino group permit a highly regioselective N-acylation with 4-(chloromethyl)benzoic acid derivatives under Schotten-Baumann conditions, while the nitrile is retained as a latent carboxamide to be unveiled in the final synthetic step via hydrogen peroxide-mediated hydrolysis under alkaline conditions at controlled exotherm. Production campaigns executed in a 500 L glass-lined reactor equipped with a retreat-curve impeller and a ΔT-controlled jacket fed a 30% w/w NaOH solution at a molar ratio of 1:2.5 relative to the nitrile, with the addition rate governed by a maximum reaction mass temperature of 68 °C. Following hydrolysis, the pH was adjusted to 2.8–3.2 using 6 M HCl to precipitate the carboxylic acid, which was isolated on a 0.6 m² Hastelloy centrifuge with a wash sequence of deionized water and acetone to remove residual inorganic salts. The wet cake was dried in a double-cone rotary vacuum dryer at 50 °C and -0.09 MPa for 14 h to achieve a loss-on-drying value of ≤0.3% and a residual acetone level ≤50 ppm, verified by headspace GC against an ICH Q3C Class 3 solvent acceptance criterion. The downstream coupling employed EDCI and HOBt in anhydrous DMF, where the carboxamide was condensed with a 2-methylpyrimidin-4-amine-bearing piperazine moiety at a mole ratio of 1.00:1.03 to ensure full consumption of the limiting reagent; the reaction endpoint was confirmed by in-process HPLC (C18, 254 nm) with a specification of residual starting material ≤0.15%. The entire sequence operated under a formal quality agreement referencing ICH Q7 Sections 7.3 (in-process controls) and 12.1 (validation of analytical procedures), with heavy metal limits governed by USP ⟨232⟩/⟨233⟩ using inductively coupled plasma mass spectrometry for palladium and iron controls. The final product, a BCR-ABL/SRC dual inhibitor monographed in the European Pharmacopoeia under a tight residual solvent specification, was produced in a 99.4% purity profile and is formulated into film-coated tablets for oncology indications. A comparative matrix of hydrolysis condition screening data from the pre-scale laboratory campaign is provided in the table below.
What Limits the Cyano Group Hydrogenation Selectivity During a One-Pot Aminothiazole-to-Amidine Synthesis?Manufacture of a broad-spectrum veterinary cephalosporin intermediate hinging on a 2-aminothiazole-4-carboxamidine scaffold exploits the susceptibility of the nitrile moiety to catalytic hydrogenation over Raney nickel in methanolic ammonia. The principal process risk is over-reduction of the thiazole ring or partial hydrogenolysis of the C–S bond when the hydrogen uptake exceeds 1.0 molar equivalent relative to the nitrile. Production data from a 2000 L Hastelloy C-276 hydrogenation vessel with a hollow-shaft gas-induction agitator operating at 1200 rpm tip speed indicate that maintaining a hydrogen partial pressure of 0.35–0.40 MPa and a temperature ramp not exceeding 2 °C/min to a final bulk temperature of 45 °C suppresses the secondary amine formation byproduct below 0.7% area-by-HPLC. The charge is assembled by dissolving 2-aminothiazole-4-carbonitrile in 7 M ammonia in methanol at a concentration of 0.4 kg/L, followed by the addition of a pre-washed Raney nickel slurry equivalent to 12% w/w of the nitrile weight on a dry basis. The reaction endpoint is signalled by the cessation of hydrogen consumption monitored via a mass-flow controller interfaced with a distributed control system; post-filtration, the catalyst cake is quenched with water under a nitrogen blanket and the filtrate is concentrated under reduced pressure at ≤40 °C to prevent amidine decomposition. In-process controls must comply with ICH Q3A thresholds for unspecified impurities (\(\leq\)0.1%) and total impurities (\(\leq\)0.5%), with structural elucidation of any new impurity exceeding the 0.05% identification threshold conducted by LC-MS/MS. The dried amidine hydrochloride is stored under argon at 2–8 °C in polyethylene-lined fibre drums to prevent deliquescence; the material is immediately consumed in the subsequent step with a chloroacetyl chloride reagent at a molar ratio of 1:1.05 in anhydrous acetonitrile to form the cephalosporin side-chain acid. The final cephalosporin formulation, a sterile injectable suspension for cattle, is subject to Ph. Eur. monograph 0988 for cephalexin-related compounds, with the aminothiazole-derived sub-structure contributing to a critical European Medicines Agency maximum residue limit compliance pathway under Regulation (EU) No 37/2010. Crystallographic Stability of the Aminothiazole Motif in Pyrethroid Bioisostere AssemblyThe integration of 2-aminothiazole-4-carbonitrile into type-II pyrethroid ester bioisosteres leverages the cyano group as a dipole-matching element that mimics the 3-phenoxybenzyl alcohol portion of traditional pyrethroid acids. Pilot-scale syntheses run at a toll manufacturer in a dedicated insecticide building employed a sequence where the amino group was first acetylated with acetic anhydride in toluene at 110 °C using a catalytic quantity of 0.5 mol% para-toluenesulfonic acid, achieving complete conversion within 3 h as determined by FTIR tracking of the nitrile stretch at 2225 cm⁻¹ remaining constant. The resulting acetamide was condensed with ethyl trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate in a Claisen-type reaction facilitated by sodium hydride dispersion (60% in mineral oil) at 1.2 molar equivalents in dimethoxyethane under reflux. The formulation ratio of the parent nitrile intermediate to the final active ester is strictly stoichiometric, but in-process adjustments of ±3% were permitted based on quantitative 1H NMR against an internal dimethyl sulfone standard. The active ingredient was recovered via drowning out into ice-water, filtration, and recrystallization from isopropanol to meet the FAO specification AGP:CP/338 for fenvalerate-type isomers, specifically a cis/trans ratio of 40:60 ± 2.5% as determined by chiral HPLC on a Chiralcel OJ-H column. The final formulation is an emulsifiable concentrate (EC) at 50 g/L of active ingredient, registered under the South Korean MFDS pesticide registration regime with a 5-batch pre-approval analysis demonstrating a 0.1% threshold for the liberated 2-aminothiazole-4-carbonitrile as a degradation marker in pH 7 buffer at 54 °C over 14 days. Implementing a solvent swap from dimethylformamide to 2-methyltetrahydrofuran for the coupling of 2-aminothiazole-4-carbonitrile with a pyrazole-4-carbonyl chloride derivative reduced the environmental factor (E-factor) from 28.2 to 9.4 across three commercial campaigns at a 2000 L scale, according to process mass intensity data filed with a Type II variation to a Marketing Authorisation for a cereal SDHI fungicide. The revised procedure charges the aminothiazole in 2-MeTHF at a concentration of 0.25 g/mL, cools the solution to −5 °C, and adds the acyl chloride—generated immediately beforehand from the corresponding carboxylic acid and oxalyl chloride with a catalytic DMF needle feed—at a precise molar ratio of 1:1.15 over 90 min while maintaining the internal temperature below 0 °C. Aqueous workup with 8% sodium bicarbonate at 5 °C followed by phase separation via a continuous centrifugal extractor (Podbielniak C-8) strips the HCl liberated during acylation without stationary aqueous hold-up exceeding 30 s, which is critical because the product amide undergoes measurable hydrolysis to the free acid above pH 8.5 at residence times beyond 2 min. The organic phase is concentrated, and the crude is crystallised from n-heptane/ethyl acetate (85:15 v/v) in a 3000 L draft-tube crystalliser with a 2 h controlled cooling ramp from 60 °C to 5 °C at a linear rate of 0.46 °C/min, yielding a polymorphic Form II seed bed with a median particle size (D50) of 28 µm as measured by laser diffraction on a Malvern Mastersizer 3000. The final amide intermediate, a pyrazole-4-carboxamide fungicide containing the aminothiazole ring as a hinge-binding motif, is registered under the OECD Guideline 502 for storage stability and subjected to 5-batch pre-licensing analysis per SANCO/10055/2013 guidance. Compliance with the US EPA’s Disinfectant/antimicrobial pesticide registration requirements (40 CFR Part 158) for technical-grade active substance specification of ≥98.0% purity and any single unknown impurity ≤0.8% was verified by an independent GLP laboratory using the CIPAC 4108/m HPLC protocol. A summary of the critical in-process control thresholds adopted across the campaign lifecycle is tabulated below.
When Diazotisation of the Aminothiazole Precedes Coupling with an N,N-Dialkylaniline Derivative at Sub-Ambient TemperatureIn the colourant sector, the presence of both a diazotisable amine and a cyano-substituted heterocycle in the same molecule makes 2-aminothiazole-4-carbonitrile a valuable heavy-diazo component for blue- to violet-shade disperse dyes targeting polyester fabrics processed under high-temperature exhaust methods. A production-scale diazotisation step is executed in a 1200 L jacketed, glass-lined vessel charged with 98% sulfuric acid and 40% nitrosylsulfuric acid at a molar ratio of nitrite to amine of 1.01, keeping the temperature rigorously at −2 to 2 °C via a brine-based secondary loop. The low temperature is mandatory: thermal runaway scenarios documented in process hazard analyses show the onset of exothermic heterocycle ring-opening at 8 °C, with a TMRad (time to maximum rate under adiabatic conditions) of less than 60 s at 15 °C, as determined by accelerating rate calorimetry (ARC) following ASTM E2618-13. The resulting diazonium salt solution is clarified through a 5 µm polypropylene filter and immediately transferred into a 3000 L coupling vessel containing a pre-dissolved coupler—typically N,N-diethyl-meta-toluidine—dispersed in an acetic acid/sodium acetate buffer at pH 3.5 and 0–5 °C. The addition rate of the diazonium stream is controlled to maintain an instantaneous molar excess of coupler of ≥5%, verified by a spot-test on sulfone paper with H-acid, preventing the accumulation of unreacted diazonium species that could decompose to a tar. The dye is isolated as a presscake on a filter press lined with polypropylene cloth, washed with chilled brine, and dried in a vacuum shelf dryer at 60 °C for 24 h to a moisture content of ≤1.0%. The final product, a monoazo disperse dye corresponding to a genericised Colour Index designation of a heterocyclic aminoazobenzene type, meets the restricted substance limits under the ZDHC Manufacturing Restricted Substances List v3.1, with specific testing for residual N,N-dialkylaniline by GC-MS at a detection threshold of 50 ppm. The dye is formulated into a granulated preparation with a lignin sulfonate dispersant for dyeing polyester at 130 °C under pressure, commonly applied in automotive upholstery specifications requiring light-fastness ratings of ≥6 on the blue wool scale under AATCC TM 16.3. Shipment and Incoming-QC Specifications for a Refrigerated Anthelmintic Intermediate Supply ChainFor a benzimidazole-thiazole hybrid anthelmintic active substance registered in New Zealand under the Agricultural Compounds and Veterinary Medicines Act 1997, 2-aminothiazole-4-carbonitrile is sourced as a pre-qualified starting material under a formal technology transfer agreement that defines a retest interval of 18 months from the date of manufacture when stored in the original, sealed, aluminium-laminated foil bag at 2–8 °C and protected from light. The incoming inspection protocol at the API manufacturer’s warehouse includes identity confirmation by Fourier-transform infrared spectroscopy against a certified reference standard, with the characteristic nitrile absorbance at 2223 cm⁻¹ (± 2 cm⁻¹) and the primary amine N–H stretches at 3410 cm⁻¹ and 3285 cm⁻¹ as mandatory acceptance bands. The limit of N,O-bis-trimethylsilylacetamide-detectable moisture is set at 0.15% by Karl Fischer titration (Ph. Eur. 2.5.12, micro method), because controlled-stress rheometry on the subsequent amidation melt at 175 °C revealed that moisture ingress beyond 0.22% catalyses a premature ring-opening pathway that drops the 6-aminobenzimidazole cyclisation yield by 7–10% absolute. During downstream processing, the nitrile is reacted with 4-chloro-ortho-phenylenediamine in polyphosphoric acid at a molar ratio of 1.00:0.98 at 130 °C for 18 h, with a final quenching and neutralisation sequence carried out in a 5000 L dedicated containment area due to the corrosive nature of the neutralised phosphate effluent. The resulting anthelmintic API is incorporated into oral drench formulations at concentrations of 50 g/L and registered with a milk withholding period of 21 days under MPI ACVM Notice NZ-10-14. Any shipment lot of the imported aminothiazole-carbonitrile that exceeds the storage temperature excursion limit of 10 °C for more than 48 cumulative hours is subject to a full re-qualification through the same panel of limit tests before release into the GMP production stream. |
Competitive 2-Aminothiazole-4-Carbonitrile prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Method | Specification |
|---|---|---|
| Appearance | Visual / USP | Pale‑yellow to off‑white crystalline powder |
| Purity (HPLC) | USP 〈621〉 | ≥99.0 % area |
| Melting point (DSC) | ASTM E794‑06 | 155–158 °C |
| Loss on drying | USP 〈731〉 | ≤0.5 % (60 °C, 4 h, vac.) |
| Residual Pd / Fe | ICP‑OES | ≤10 ppm |
| Water content (KF) | USP 〈921〉 | ≤0.3 % |
| Compound | CAS | Melting Point (°C) | Nitrile Reactivity (krel with NH₂OH) | Key Distinction |
|---|---|---|---|---|
| 2‑Aminothiazole‑4‑carbonitrile | 55379‑24‑5 | 155‑158 | 1.0 | Activated 4‑CN; selective amidoxime/tetrazole formation at ambient temperature |
| 2‑Aminothiazole‑5‑carbonitrile | 113852‑45‑6 | 142‑145 | 0.12 | Slower nucleophilic addition; requires elevated temperature and longer reaction times |
| 4‑Aminothiazole‑2‑carbonitrile | 21531‑65‑5 | 168‑170 (dec) | N/A (amino adjacent to CN) | Competing tautomerisation; less suitable for sequential derivatisation |
| Standard / Regulation | Scope | Status |
|---|---|---|
| EU REACH (EC 1907/2006) | Registration, classification & labelling | Pre‑registered; no SVHC identification |
| ICH Q3C (R8) / USP 〈467〉 | Residual solvents | Class 2 solvents below permissible daily exposure |
| ISO 9001:2015 | Quality management system | Manufactured under certified QMS |
| EC 2011/65/EU (RoHS 3) | Restricted substances | Article category 9 exempt; not intentionally added |
| FDA 21 CFR 177.2600 | Indirect food contact (rubber articles) | (Not formulated for direct food contact; technical rubber analysis available) |